Good morning. I'm Ben Zeskind, the Co-founder, President, CEO, a member of the Board of Directors, and the Chairperson of today's meeting. I'm very happy to welcome you to our 2026 annual meeting of stockholders. On behalf of Immuneering, thank you for attending today and for your support of the company. Before I call the meeting to order, I'd like to introduce the other members of the Board of Directors who are with us today. The other members of the Board are Dr. Thomas J. Schall, our Chair of the Board, Robert J. Carpenter, Peter Feinberg, Dr. Diana S. Hausman, and Laurie B. Keating. In addition, participating today is Michael Bookman, our Chief Legal Officer and Secretary. Also joining us are representatives of RSM US LLP, the company's independent registered public accounting firm, who are available to respond to relevant questions raised during the meeting.
The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in the notice of annual meeting and proxy statement. The time is 11:01 A.M. Eastern Time on June 11th, 2026, and the polls are now open for voting on all matters before the meeting. If you have not already voted and wish to vote, the polls will remain open until we finish presenting the proposals and close the polls. You do not need to vote during the meeting if you already voted and do not wish to change your vote. Upon joining the meeting, an agenda for the meeting should have become available on your screen. Also available at the bottom of your screen is a list of the rules of conduct for the meeting. To conduct an orderly meeting, we ask that participants please abide by these rules.
We will be responding to appropriate questions raised regarding the matters to be voted on at this meeting. If you would like to submit a question, you may enter your question in the question and answer function on the annual meeting webpage. You must include your name and, if applicable, organization with your question. Each stockholder will be able to ask up to two questions. Note that only stockholders who are logged into the meeting using their 16-digit control number will be able to vote and submit questions at today's meeting. Our secretary will file the proof of mailing the notice of meeting to stockholders of record on the record date with the company's records of the meeting. All stockholders of record at the close of business on April 15th, 2026, or holders of a valid proxy, are entitled to vote at the meeting.
At this time, I'd like to introduce Cheryl Niebeling, a representative of Broadridge Investor Communications Services. The Board of Directors has appointed a representative of Broadridge to act as inspector of election at today's meeting. Ms. Niebeling has signed the customary oath of office to execute her duties with strict impartiality. We will file this oath with the records of the meeting. I have been informed that a quorum is present. Therefore, I hereby declare this meeting to be duly constituted for the transaction of business. We will now proceed with the formal business of this meeting. There are two proposals to be considered by the stockholders at today's meeting. The company recommends that the stockholders vote for each of the director nominees named in the first proposal and for the second proposal.
The first item of business is the election of Peter Feinberg and Laurie B. Keating to serve as Class II directors of the company to hold office until the company's annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. The second item of business is the ratification of the audit committee's appointment of RSM US LLP as the company's independent registered public accounting firm for the 2026 fiscal year. This is the final proposal for today's meeting. As a reminder, for the purposes of today's meeting, we welcome only those questions from stockholders about the two proposals discussed. Please submit these questions via the question and answer text box on the annual meeting page. We will now take questions. Michael, are there any questions?
Ben, there are no questions.
Thank you, Michael. There are no more questions at this time. If you wish to vote and you haven't already, please vote now by clicking on the voting button on the web portal and following the instructions. You do not need to vote electronically if you have already sent in your signed proxy or if you have previously voted by telephone or internet, unless you wish to change your vote. We will pause for approximately 30 seconds before closing the voting polls. The time is now 11:05 A.M. Eastern Time, and the polls are now closed for voting. The inspector of election will count the votes. Thank you very much. I have received the preliminary report of the inspector of election to be kept with the company's records of the annual meeting.
Based on the preliminary report of the inspector of election, each of Peter Feinberg and Laurie B. Keating have been elected as a Class II director to serve until the company's annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. The appointment of RSM US LLP as the company's independent registered public accounting firm for the 2026 fiscal year has been ratified. We intend to publish the final tally of the votes within four business days in a current report on Form 8-K to be filed with the United States Securities and Exchange Commission. It is now 11:06 A.M. Eastern Time, and the formal portion of the meeting has concluded.
With that, ladies and gentlemen, this concludes our annual meeting, and the meeting is now adjourned. I want to once again thank you for attending and for your continued support of Immuneering.
Ladies and gentlemen, you may now disconnect.